Tamro Estonia, Tamro Latvia and Tamro Lithuania

Total pharmaceutical sales in Estonia during January–September 2009 amounted to EUR 136 (136) million in PPP, an increase of 0.8% at CER compared to the same period in the previous year. Tamro’s net sales in Estonia during February–October were EUR 60 (61) million, a decrease of 2.8%. The company employed an average of 342 (316) people, of whom 78% worked in retail.

Total pharmaceutical sales in Latvia during February–October 2009 were EUR 192 (214) million in PPP, a decrease of 10.4% at CER compared to the same period in the previous year. Tamro’s net sales in Latvia during February–October were EUR 79 (88) million, a decrease of 9.7%. The company employed an average of 425 (413) people, of whom 75% worked in retail.

Total pharmaceutical sales in Lithuania during February–October 2009 totalled EUR 300 (316) million in PPP, a decrease of 5.1% at CER compared to the same period in the previous year. Tamro’s net sales in Lithuania during February–October were EUR 65 (77) million, a decrease of 15.8%. The company employed an average of 590 (443) people, of whom 81% worked in retail.

The general economic downturn affected the pharmaceutical market growth negatively in all Baltic countries. The pharmaceutical sales are not expected to grow for the rest of the financial year 2009/10. Tamro’s strong costs saving measures in the Baltic countries compensated some of the negative impact of the economic downturn.